Hypoglycaemia is a feared complication of insulin-treated diabetes. Treatment recommendations vary worldwide and their implementation is poorly documented. The primary study objective was to assess adherence to broad guidelines of hypoglycaemic treatment; initially with quick-acting carbohydrate and follow up with long-acting carbohydrate. The secondary objective was to assess if initial treating carbohydrate quantity complied with current worldwide recommendations. Assessment was by questionnaire, which was validated, piloted and administered to all insulin-treated individuals attending routine outpatient diabetes clinic appointments over four weeks. The questionnaire response rate, readability and validity were acceptable at 74%, grade 6 level and 0.61 (Cohen's kappa), respectively. Assessment of broad guidelines for treatment of hypoglycaemia showed 78% of responders reported initial treatment with recommended foods, but only 40.8% of these were quick-acting carbohydrate. Only 55.8% reported ingesting follow-up food. Assessment of initial treating carbohydrate quantity showed 20.6% of responders used quantities exceeding all guidelines. Of the remaining, 46.4% used quantities consistent with the most liberal recommendations (European Association for the Study of Diabetes). Most study participants reported treating with recommended foods in quantities exceeding minimum recommendations, possibly attempting to resolve unpleasant symptoms of hypoglycaemia quickly. Failure of many to ingest follow-up food is concerning and warrants investigation. Increased patient education and standardisation of guidelines for treatment of hypoglycaemia are indicated. Copyright (C) 2012 John Wiley & Sons.
机构:
Univ Sheffield, Acad Unit Diabet Endocrinol & Metab, Sheffield, S Yorkshire, EnglandUniv Sheffield, Acad Unit Diabet Endocrinol & Metab, Sheffield, S Yorkshire, England
Heller, S. R.
Frier, B. M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, ScotlandUniv Sheffield, Acad Unit Diabet Endocrinol & Metab, Sheffield, S Yorkshire, England
Frier, B. M.
Herslov, M. L.
论文数: 0引用数: 0
h-index: 0
机构:
Novo Nordisk AS, Med & Sci, Soborg, DenmarkUniv Sheffield, Acad Unit Diabet Endocrinol & Metab, Sheffield, S Yorkshire, England
Herslov, M. L.
Gundgaard, J.
论文数: 0引用数: 0
h-index: 0
机构:
Novo Nordisk AS, Hlth Econ & HTA, Soborg, DenmarkUniv Sheffield, Acad Unit Diabet Endocrinol & Metab, Sheffield, S Yorkshire, England
Gundgaard, J.
Gough, S. C. L.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Oxford, Acad Hlth Sci Network, NIHR Oxford Biomed Res Ctr, Oxford Ctr Diabet Endocrinol & Metab, Oxford, EnglandUniv Sheffield, Acad Unit Diabet Endocrinol & Metab, Sheffield, S Yorkshire, England